Y
Y-mAbs Therapeutics
Biotech & Life Sciences · New York City, United States · Founded 2014 · IPO 2018 Unicorn
Investors
2 investors on Y-mAbs Therapeutics's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where Y-mAbs Therapeutics has talent and traffic
team presence
across markets
Patent intelligence
$435k patent portfolio · 8 active families
Where Y-mAbs Therapeutics concentrates vs peers
Each axis is a top-10 topic across Y-mAbs Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Y-mAbs Therapeutics
An AI-synthesized read of the highest-engagement posts about Y-mAbs Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Y-mAbs Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.